Foresite Capital Management II, LLC is 10% Owner at 10x Genomics, Inc. (TXG). They have made 3 open-market trades across 2 companies since 2016, most recently 2020-05-13.
CIK 0001594912
1 open-market purchase totalling $4.4M since 2016, against 2 sales. Too few scored purchases to measure a record yet.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.